A team of researchers based in Portugal and the United Kingdom recently conducted a study that examined cannabinoid levels in products in Portugal. They found that many of the products were mislabeled and did not contain the levels of cannabinoids that were listed on the product’s labels.
“Our study, conducted with products available in Portugal, revealed significant discrepancies between label claims and actual cannabinoid compositions.” the researchers stated about their study, which was published in the peer-reviewed open access scientific journal Molecules.
“A fully validated method was developed for the characterisation of different products acquired from pharmacies and street shops (beverages, herbal samples, oils, and cosmetic products) using high-performance liquid chromatography coupled with a diode array detector.” the researchers stated about their methods.
“Among sampled beverages, none contained detectable cannabinoids, despite suggestive packaging. Similarly, oils often differed from the declared cannabinoid compositions, with some containing significantly higher CBD concentrations than labelled.” the researchers stated about the results of the products that they tested.
“These inconsistencies raise serious concerns regarding consumer safety and informed decision-making. Moreover, our findings underscore the need for stringent regulation and standardised testing protocols to ensure the accuracy and safety of cannabis-based products.” the study’s authors concluded.
The global medical cannabis industry is projected to reach an estimated $77.13 billion in value by 2032 according to a new market report by Straits Research. Straits Research describes itself as “a market intelligence company providing global business information reports and services.”
“As per the latest report by Straits Research, the global medical cannabis market size was valued at USD 17,075.39 million in 2023. It is expected to reach USD 77,134.83 million by 2032, growing at a CAGR of 18.24% during the forecast period (2024–2032).” Straits Research stated in a press release.
The global medical cannabis market is projected to be worth an estimated $121.33 billion by 2033 according to a separate analysis by Spherical Insights. Spherical Insights describes itself as “a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.”
“The Global Medical Cannabis Market Size is to Grow from USD 17.60 Billion in 2023 to USD 121.33 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 21.30% during the projected period.” Spherical Insights stated in a press release.